Clinical Trial Update: Efficacy of Venetoclax in Combination With Rituximab in Waldenström's Macroglobulinemia [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating the efficacy of venetoclax in combination with rituximab for Waldenström macroglobulinemia. The study is currently recrui…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Waldenström Macroglobulinemia

Drugs mentioned

• Rituximab (rituximab)
• Venetoclax (venetoclax)

Snippet

Sponsor: Christian Buske | Conditions: Waldenstrom Macroglobulinemia, Treatment Naive | Phase 2 | Status: RECRUITING